Schrodinger

Historical price data

Schrödinger is a computational science pioneer with a dual-business model combining high-margin software licensing with internal drug discovery. Founded in 1990, the company has built a sophisticated, physics-based platform that is widely adopted by pharmaceutical and materials science organizations. Its strategy validates its technology through internal deployment in a therapeutic pipeline, aiming to create diversified revenue streams and capture value across the discovery value chain.

An integrated, physics-based computational platform for molecular modeling and design, combining advanced molecular dynamics (FEP+), machine learning, and enterprise informatics to accelerate drug and materials discovery.

Faces competition from AI/ML-focused drug discovery software firms (e.g., Relay Therapeutics, Exscientia) and competes as a biotech against all companies pursuing similar oncology targets. Its key differentiation is a deep physics-based computational foundation integrated with a proprietary therapeutic pipeline.